Evidence map›Paper›PMID 32486229›Full record

ArticleInternational journal of molecular sciences2020

Investigation of Some Antiviral

Mohamed Hagar, Hoda A Ahmed, Ghadah Aljohani, Omaima A Alhaddad

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. RSC advances · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed HagarChemistry Department, College of Sciences, Yanbu, Taibah University, Yanbu 30799, Saudi Arabia.
Hoda A AhmedDepartment of Chemistry, Faculty of Science, Cairo University, Cairo 12613, Egypt.ORCID 0000-0003-3966-7024
Ghadah AljohaniChemistry Department, College of Sciences, Al-Madina Al-Munawarah, Taibah University, Al-Madina 30002, Saudi Arabia.ORCID 0000-0003-0406-416X
Omaima A AlhaddadChemistry Department, College of Sciences, Al-Madina Al-Munawarah, Taibah University, Al-Madina 30002, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic that started in December 2019. The effective drug target among coronaviruses is the main protease M

Indexed as

Molecular Docking SimulationAmidesAmodiaquineAntiviral AgentsBinding SitesCoronavirus 3C ProteasesCysteine EndopeptidasesProtease InhibitorsProtein BindingPyrazinesRibavirinViral Nonstructural ProteinsAmidesAmodiaquineAntiviral AgentsCoronavirus 3C ProteasesCysteine EndopeptidasesfavipiravirProtease InhibitorsPyrazinesRibavirinViral Nonstructural ProteinsCOVID 19DFT calculationshydroxychloroquinemolecular dockingN-heterocycles

Identifiers

PMID32486229
PMCPMC7312990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.